← Evidence map

TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer.

Ryan B Corcoran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

286 papers cite itlatest 60 shown

2015
…
2018
2019
2020
2021
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26392102